Bressan, R. A., Erlandsson, K., Jones, H. M. et al.: Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I] epidepride SPET study of amisulpride-treated patients. Am. J. Psychiatry, 160: 1413-1420, 2003.
Bymaster, F. P., Rasmussen, K., Calligaro, D. O. et al.: In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug. J. Clin. Psychiatry, 58 (suppl. 10): 28-36, 1997.
Gyertyán, I. and Sághy, K.: The selective dopamine D3 receptor antagonists, SB 277011-A and S 33084 block haloperidol-induced catalepsy in rats. Eur. J. Pharmacol., 572: 171-174, 2007.
Hedlund, P. B. and Sutcliffe, J. G.: Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends. Pharmacol. Sci., 25: 481-486, 2004.